Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder

Clinical trial NCT03539900 · COMPLETED

Trial details

NCT number: NCT03539900
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Binge-Eating Disorder

Start date: 2018-04-17
Primary completion: 2022-04-19
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.